Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2024 | The importance of shared-decision making when treating infants with hemophilia

Jayashree Motwani • 28 Apr 2024
BSH 2024
Hemophilia Non-Malignant

Jayashree Motwani, MBBS, FRCPath, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK, briefly discusses some considerations for physicians when treating infant patients with hemophilia, highlighting the importance of a shared-decision making approach in which the families of patients are provided with the knowledge to make informed decisions about the care of the child. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Related Videos

1:46
Treosulfan versus busulfan-based conditioning for HSCT in transfusion-dependent thalassemia
Rita Beier • 15 Apr 2024
2:40
What can clinicians do to address the impact of transfusion-dependent thalassemia on patients' QoL?
Farrukh Shah • 30 Apr 2024
2:27
Optimizing the delivery of care for patients with hemoglobinopathies in the UK
Farrukh Shah • 30 Apr 2024
2:24
Primary prevention against atherosclerosis in patients with hemophilia
Beverley Hunt • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals